Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biophysics, ibidi, Thermo Electron

Premium

Applied Biophysics and ibidi Extend Partnership

Applied Biophysics and German microscope supply firm ibidi this week extended their product-distribution partnership.

Under the terms of the deal, ibidi will exclusively distribute Applied Biophysics' products in Germany.

Applied Biophysics currently distributes ibidi's u-slide "Lab-on-a-slide" technology for analyzing cells and molecules in the US.

Applied Biophysics markets the ECIS (Electric Cell-substrate Impedance Sensing) technology for measuring changes in live cells based on changes in electrical impedance in a cell layer.


Acquisitions Fuel 21-Percent Revenue Growth for Thermo Electron in Q4; LLS Receipts Surge 24 Percent

Thermo Electron this week said that fourth-quarter revenue for its Life and Laboratory Sciences division increased 24 percent, while acquisitions caused overall receipts for the company to grow 21 percent.

Total receipts for the LLS segment during the three months ended Dec. 31 increased to $563 million from $455 million year over year.

Companywide revenue increased to $741 million from $613 million in the year-ago period, though 19 percent of that growth was the result of acquisitions, Thermo said. Unfavorable currency translation cost the company 4 percent in revenue growth, the firm said.

"We experienced very strong growth from our industrial markets, especially in commodity materials and environmental monitoring," President and CEO Marijn Dekkers said in a statement. "In addition, growth from our life sciences customers continued at a good pace."

R&D spending in the fourth quarter increased 9 percent to $38 million from $35 million year over year, Thermo said.

Thermo said it had around $214 million in cash and equivalents and $80 million in short-term investments as of Dec. 31.

Looking ahead, Thermo said it expects total revenue in 2006 to grow between 6 percent and 8 percent year over year to between $2.78 billion and $2.83 billion.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.